CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Health First

Frank Wang, System Vice President, IDN Decision Support Analytics

Future Predictive Analytics Solutions need the Right Level of Regulatory Governance

Frank Wang

Frank Wang

In the past more than a decade or so, big data and predictive analytics has enjoyed the encouraging development and growth environment. The impact of the big data and predictive analytics to our daily lives is tremendous. Big data and predictive analytics is part of a business operation process and crucial to the outcome from targeted marketing to clinical interventions and recommending treatment pathways. The dynamic, independent, developer centric and open source style for developing the logic/algorithm for implementing the big data and predictive analytics solutions generates some scale of variations and confusions regarding to the predictive model build and the predicted outcomes. It is anticipated that the future predictive analytics solutions need the right level of regulatory governance in the following seven major areas in order to continuing grow smoothly.


"As a provider of analytics solutions or a data science team in an organization, it is important to take proactive approach to adopt the best practices in the development life cycle"


1. Share the purpose and motivation for using a specific algorithm to help building the trust and understanding of the analytical insights when adopting an analytics solution. To reduce the “black box” barrier on the end user side will help to utilize the business users’ expertise in the process improvement and improve the buy-in status from the end users. The impacted individuals need to be aware of why and how an analytics solution is used in the decision-making process.


2. Standardize the data partition in the whole development life cycle of model development, validation and testing. An industry standard for testing and valid an analytics performance needs to be adopted by data scientists. The approach for choosing the data for building a model validate a model and test a model greatly affect the precision for the prediction.


3. Make it transparent of what data is used in the analytics solution and how the data is collected and used. To explain to the consumers of an analytics solution how a data set is used will help to build trust and reach the outcome as expected. This is crucial for building the coordination between the impacted entities.


4. Authorized agencies need to help and assess the fundamental crucial features and core performance measures of an analytics system. For example, FDA need to work with the industries to provide the clinical decision support analytics guidelines.


5. Standardize the analytics system trial and validation process. The feedback loop for analytics solutions is relatively long, especially for healthcare predictive analytics solutions. It will take very long time to validate the predicted clinical outcomes in healthcare industry. A standard trial protocol needs to be agreed and followed for developing predictive analytics solutions.


6. Publish and share the performance data for major commercial analytics solutions. The authorized agencies need to maintain and share the standard performance measures for the analytics solutions to help the uses to assess the predictive modeling methodologies and pick the proper solutions.


7. Set up a center for testing the commercial analytics solution, guided by the authorized agencies. To share and public the standard performance by the center will help the users to select the right solutions as addition to their analytics tool kit.


As a provider of analytics solutions or a data science team in an organization, it is important to take proactive approach to adopt the best practices in the development life cycle to be prepared in the seven areas discussed. We will have a more detail discussion in a separate article.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/future-predictive-analytics-solutions-need-the-right-level-of-regulatory-governance-nwid-320.html